These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 23754115)
1. Cyclic tetrapeptides with -SS- bridging between amino acid side chains for potent histone deacetylases' inhibition. Arai T; Ashraful Hoque M; Nishino N; Kim HJ; Ito A; Yoshida M Amino Acids; 2013 Oct; 45(4):835-43. PubMed ID: 23754115 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of functional groups on amino acids in cyclic tetrapeptides in histone deacetylase inhibition. Islam MS; Bhuiyan MP; Islam MN; Nsiama TK; Oishi N; Kato T; Nishino N; Ito A; Yoshida M Amino Acids; 2012 Jun; 42(6):2103-10. PubMed ID: 21638021 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of mono and bicyclic tetrapeptides thioester as potent inhibitor of histone deacetylases. Hoque MA; Islam MS; Islam MN; Kato T; Nishino N; Ito A; Yoshida M Amino Acids; 2014 Oct; 46(10):2435-44. PubMed ID: 25048030 [TBL] [Abstract][Full Text] [Related]
4. The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor. Yurek-George A; Cecil AR; Mo AH; Wen S; Rogers H; Habens F; Maeda S; Yoshida M; Packham G; Ganesan A J Med Chem; 2007 Nov; 50(23):5720-6. PubMed ID: 17958342 [TBL] [Abstract][Full Text] [Related]
5. Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases. Hoque MA; Arai T; Nishino N; Kim HJ; Ito A; Yoshida M Bioorg Med Chem Lett; 2012 Nov; 22(21):6770-2. PubMed ID: 23021104 [TBL] [Abstract][Full Text] [Related]
6. Chlamydocin-hydroxamic acid analogues as histone deacetylase inhibitors. Nishino N; Jose B; Shinta R; Kato T; Komatsu Y; Yoshida M Bioorg Med Chem; 2004 Nov; 12(22):5777-84. PubMed ID: 15498654 [TBL] [Abstract][Full Text] [Related]
7. Discovery of potent HDAC inhibitors based on chlamydocin with inhibitory effects on cell migration. Wang S; Li X; Wei Y; Xiu Z; Nishino N ChemMedChem; 2014 Mar; 9(3):627-37. PubMed ID: 24285590 [TBL] [Abstract][Full Text] [Related]
8. Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework. Shivashimpi GM; Amagai S; Kato T; Nishino N; Maeda S; Nishino TG; Yoshida M Bioorg Med Chem; 2007 Dec; 15(24):7830-9. PubMed ID: 17881232 [TBL] [Abstract][Full Text] [Related]
9. Bicyclic tetrapeptides as potent HDAC inhibitors: effect of aliphatic loop position and hydrophobicity on inhibitory activity. Islam MN; Islam MS; Hoque MA; Kato T; Nishino N; Ito A; Yoshida M Bioorg Med Chem; 2014 Aug; 22(15):3862-70. PubMed ID: 25022972 [TBL] [Abstract][Full Text] [Related]
10. Total synthesis of the bicyclic depsipeptide HDAC inhibitors spiruchostatins A and B, 5''-epi-spiruchostatin B, FK228 (FR901228) and preliminary evaluation of their biological activity. Narita K; Kikuchi T; Watanabe K; Takizawa T; Oguchi T; Kudo K; Matsuhara K; Abe H; Yamori T; Yoshida M; Katoh T Chemistry; 2009 Oct; 15(42):11174-86. PubMed ID: 19760730 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, evaluation and molecular modeling of cyclic tetrapeptide histone deacetylase inhibitors as anticancer agents. Huang D; Li X; Sun L; Xiu Z; Nishino N J Pept Sci; 2012 Apr; 18(4):242-51. PubMed ID: 22253009 [TBL] [Abstract][Full Text] [Related]
12. Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones. Jose B; Oniki Y; Kato T; Nishino N; Sumida Y; Yoshida M Bioorg Med Chem Lett; 2004 Nov; 14(21):5343-6. PubMed ID: 15454224 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of a potent histone deacetylase inhibitor. Liu T; Kapustin G; Etzkorn FA J Med Chem; 2007 May; 50(9):2003-6. PubMed ID: 17419603 [TBL] [Abstract][Full Text] [Related]
14. An efficient synthesis of SK-658 and its analogs as potent histone deacetylase inhibitors. Shahidul Islam M; Nurul Islam M; Ashraful Hoque M; Nishino N; Kato T; Kim HJ; Ito A; Yoshida M Bioorg Chem; 2015 Apr; 59():145-50. PubMed ID: 25797804 [TBL] [Abstract][Full Text] [Related]
15. Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides. Olsen CA; Ghadiri MR J Med Chem; 2009 Dec; 52(23):7836-46. PubMed ID: 19705846 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel FK228 analogues as potential isoform selective HDAC inhibitors. Narita K; Matsuhara K; Itoh J; Akiyama Y; Dan S; Yamori T; Ito A; Yoshida M; Katoh T Eur J Med Chem; 2016 Oct; 121():592-609. PubMed ID: 27318982 [TBL] [Abstract][Full Text] [Related]
17. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity. Komatsu Y; Tomizaki KY; Tsukamoto M; Kato T; Nishino N; Sato S; Yamori T; Tsuruo T; Furumai R; Yoshida M; Horinouchi S; Hayashi H Cancer Res; 2001 Jun; 61(11):4459-66. PubMed ID: 11389076 [TBL] [Abstract][Full Text] [Related]
18. [Structure-activity relationships of histone deacetylase inhibitors]. Tan YM; Huang WY; Yu NF Yao Xue Xue Bao; 2009 Oct; 44(10):1072-83. PubMed ID: 20055127 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222. Terracciano S; Di Micco S; Bifulco G; Gallinari P; Riccio R; Bruno I Bioorg Med Chem; 2010 May; 18(9):3252-60. PubMed ID: 20381359 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors. Pabba C; Gregg BT; Kitchen DB; Chen ZJ; Judkins A Bioorg Med Chem Lett; 2011 Jan; 21(1):324-8. PubMed ID: 21109435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]